Delivery technologies for genome editing

Yin, Hao, Kauffman, Kevin J., Anderson, Daniel G.·2017·Nature Reviews Drug Discovery

Cited by (597)

Items 301–400 of 597

  1. Cargo‐Templated Crosslinked Polymer Nanocapsules and Their Biomedical Applications
    Yu Zhao, Qiushi Li, Jingshan Chai, Yang Liu · 2021 · Advanced NanoBiomed Research
  2. Nanoscale metal–organic frameworks for the intracellular delivery of CRISPR/Cas9 genome editing machinery
    Qizhen Zheng, Wenting Li, Lanqun Mao, Ming Wang · 2021 · Biomaterials Science
  3. Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
    Alessandro Allegra, Mario Di Gioacchino, Alessandro Tonacci, Claudia Petrarca, Sebastiano Gangemi · 2021 · Nanomaterials
  4. Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing
    Kemao Xiu, Laura Saunders, Luan Wen, Jinxue Ruan, Ruonan Dong, Jun Whi Song, Dongshan Yang, Jifeng Zhang, Jie Xu, Y. Eugene Chen et al. · 2022 · Cells
  5. Developing preclinical models of neuroblastoma: driving therapeutic testing
    Kimberly J. Ornell, Jeannine M. Coburn · 2019 · BMC Biomedical Engineering
  6. Co-delivery of AKT3 siRNA and PTEN Plasmid by Antioxidant Nanoliposomes for Enhanced Antiproliferation of Prostate Cancer Cells
    Stuti Bhagat, Sanjay Singh · 2020 · ACS Applied Bio Materials
  7. CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
    Imran Noorani, Allan Bradley, Jorge De La Rosa · 2020 · Genome biology
  8. The use of adenoviral vectors in gene therapy and vaccine approaches
    Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura · 2022 · Genetics and Molecular Biology
  9. Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier
    Ruosen Xie, Yuyuan Wang, Jacobus C. Burger, Dongdong Li, Min Zhu, Shaoqin Gong · 2023 · Med-X
  10. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
    Rossana Caldara, Valentina Tomajer, Paolo Monti, Valeria Sordi, Antonio Citro, Raniero Chimienti, Chiara Gremizzi, Davide Catarinella, Stefano Tentori, Vera Paloschi et al. · 2023 · Frontiers in Immunology
  11. CRISPR‐Cas9 delivery strategies and applications: Review and update
    Ali Alizadeh Severi, Bahman Akbari · 2024 · genesis
  12. Light‐Triggered Genome Editing: Cre Recombinase Mediated Gene Editing with Near‐Infrared Light
    Demosthenes Morales, Erin Morgan, Meghan McAdams, Amanda B. Chron, Jeong Eun Shin, Joseph A. Zasadzinski, Norbert O. Reich · 2018 · Small
  13. Immunotherapy perspectives in the new era of B-cell editing
    Natsuko Ueda, Marine Cahen, Yannic Danger, Jérôme Moreaux, Christophe Sirac, Michel Cogné · 2021 · Blood Advances
  14. Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy
    Yirui Feng, Yu Li, Pingping Shen, Bin Wang · 2022 · Stem Cell Reviews and Reports
  15. Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
    Eun-Jeong Won, Hyeji Park, Tae‐Jong Yoon, Young‐Seok Cho · 2022 · Pharmaceutics
  16. Genetically Engineering the Nervous System with CRISPR-Cas
    Alfredo Sandoval, Hajira Elahi, Jonathan E. Ploski · 2020 · eNeuro
  17. Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
    A. Khurana, Yi Lin · 2022 · Current Treatment Options in Oncology
  18. Small molecules convey big messages: Boosting non-viral nucleic acid delivery with low molecular weight drugs
    Freya Joris, Stefaan C. De Smedt, Koen Raemdonck · 2017 · Nano Today
  19. mRNA vaccine development and applications: A special focus on tumors (Review)
    Bangjie Chen, Yipin Yang, Xinyi Wang, Wenzhi Yang, You Lu, Daoyue Wang, Enba Zhuo, Yanchao Tang, Junhong Su, Guozheng Tang et al. · 2024 · International Journal of Oncology
  20. Precision gene editing: The power of CRISPR-Cas in modern genetics
    Jeong H. Joo, Soogene Lee, Keun Pil Kim · 2025 · Molecular Therapy — Nucleic Acids
  21. Branch-PCR constructed TP53 gene nanovector for potential cancer therapy
    Longhuai Cheng, Huiting Deng, Dejun Ma, Beibei Zhai, Qiangzhe Zhang, Luyuan Li, Zhen Xi · 2018 · Chemical Communications
  22. Efficient non-viral delivery of macromolecules in human primary hematopoietic stem cells and lymphocytes
    Zhang Chuan-ping, Hou-Yuan Qiu, Caixiang Zhang, Yuming Zhang, Yizhou Zhang, Hao Yin, Ke‐Qin Zhang, Ying Zhang · 2023 · Journal of Molecular Cell Biology
  23. The Dawn of In Vivo Gene Editing Era: A Revolution in the Making
    Sarfaraz K. Niazi · 2023 · Biologics
  24. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems
    Guillermo Aquino‐Jarquín · 2023 · Drug Discovery Today
  25. Histidine-Rich Protein Accelerates the Biomineralization of Zeolitic Imidazolate Frameworks for In Vivo Protein Delivery
    Qizhen Zheng, Jinhan Sheng, Ji Liu, Xianghan Chen, Ming Wang · 2023 · Biomacromolecules
  26. Roadmap for an early gene therapy for cystic fibrosis airway disease
    Marianne Sylvia Carlon, Dragana Vidović, Susan E. Birket · 2017 · Prenatal Diagnosis
  27. Therapeutic Application of Genome Editing Technologies in Viral Diseases
    Tae Hyeong Kim, Seong‐Wook Lee · 2022 · International Journal of Molecular Sciences
  28. Current Designs of Polymeric Platforms Towards the Delivery of Nucleic Acids Inside the Cells with Focus on Polyethylenimine
    Fernando Augusto de Oliveira, Lindomar J. C. Albuquerque, Gwendoline Delecourt, Véronique Bennevault, Philippe Guégan, Fernando Carlos Giacomelli · 2021 · Current Gene Therapy
  29. One ternary nucleic acid delivery system with smart dextran-peptide coating enables in vivo and ex vivo wound therapy
    Yaqian Fan, Peilang Yang, Hongyang Ma, Yan Liu, Xiaokang Ding, Yang Hu, Gang Cheng, Fu‐Jian Xu · 2022 · Matter
  30. Cell-penetrating peptides for medical theranostics and targeted drug delivery
    Yue‐Wern Huang, Han‐Jung Lee · 2017 · Elsevier eBooks
  31. Latest progress in the study of nanoparticle-based delivery of the CRISPR/Cas9 system
    Mingyu Yu, Xiaowen Liu, Hongbo Cheng, Longhao Kuang, Shaochong Zhang, Xiaohe Yan · 2021 · Methods
  32. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
    Behnom Farboud, Erin Jarvis, Theodore L. Roth, Jiyung J. Shin, Jacob E. Corn, Alexander Marson, Barbara J Meyer, Nipam H. Patel, Megan L. Hochstrasser · 2018 · Journal of Visualized Experiments
  33. CRISPR/Cas9 genome engineering in hematopoietic cells
    Duran Sürün, Harald von Melchner, Frank Schnütgen · 2018 · Drug Discovery Today Technologies
  34. Organoids as predictive platforms: advancing disease modeling, therapeutic innovation, and drug delivery systems
    Ting Hsiang Huang, Wei Tao Huang, Qiong Bian · 2025 · Journal of Controlled Release
  35. Assembly of Building Blocks by Double-End-Anchored Polymers in the Dilute Regime Mediated by Hydrophobic Interactions at Controlled Distances
    Emily A. Wonder, Kai K. Ewert, Chenyu Liu, Victoria M. Steffes, Jasmin Kwak, Vikar Qahar, Ramsey N. Majzoub, Zhening Zhang, Bridget O Carragher, Clinton S. Potter et al. · 2020 · ACS Applied Materials & Interfaces
  36. X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune system
    Martin W. LaFleur, Ashlyn M. Lemmen, Ivy S. L. Streeter, Thao H. Nguyen, Lauren E. Milling, Nicole M. Derosia, Zachary M. Hoffman, Jacob E. Gillis, Qin Tjokrosurjo, Samuel C. Markson et al. · 2023 · Nature Immunology
  37. Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases?
    Ina Guri, Yara Alrokh, Young‐Ah Kim, Ruhina Maeshima, Carina Graham, Stephen L. Hart, John Alexander McGrath, J. Jackow · 2023 · British Journal of Dermatology
  38. Enhancing gene transfection of poly(β-amino ester)s through modulation of amphiphilicity and chain sequence
    Zhili Li, Rui Guo, Zhiyong Zhang, Haiyang Yong, Lei Guo, Zhengju Chen, Dongdong Huang, Dezhong Zhou · 2024 · Journal of Controlled Release
  39. Current status, challenges and prospects of antifouling materials for oncology applications
    Yingfeng Zhang, Congcong Sun · 2024 · Frontiers in Oncology
  40. Gene editing in common cardiovascular diseases.
    Anna-Maria Lauerer, Xurde M. Caravia, Lars S. Maier, Francesco Chemello, S. Lebek · 2024 · Pharmacology and Therapeutics
  41. Current developments in gene therapy for epidermolysis bullosa
    Thomas Köcher, Igor Petković, Johannes Bischof, Ulrich Koller · 2022 · Expert Opinion on Biological Therapy
  42. Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy
    Shiwen Xi, Yong‐Guang Yang, Jian Suo, Tianmeng Sun · 2022 · Frontiers in Bioengineering and Biotechnology
  43. Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox
    Jessica A. Kretzmann, Kelly L. Irving, Nicole M. Smith, Cameron W. Evans · 2021 · NAR Cancer
  44. CRISPR/Cas9: an overview of recent developments and applications in cancer research
    Shamjetsabam Nandibala Devi, Rashmi Rana, Priyanka Malik, Nirmal Kumar Ganguly · 2024 · International Journal of Surgery
  45. Preclinical Advances in LNP-CRISPR Therapeutics for Solid Tumor Treatment
    Shuting Wang, Yuxi Zhu, Shi Du, Yunsi Zheng · 2024 · Cells
  46. Role of gene therapy in Fanconi anemia
    Shameel Shafqat, Eleze Tariq, Aric D. Parnes, Majed Dasouki, Syed Osman Ahmed, Shahrukh Khurshid Hashmi · 2021 · Hematology/Oncology and Stem Cell Therapy
  47. Boosting transfection efficiency: A systematic study using layer-by-layer based gene delivery platform.
    Y. Tarakanchikova, Dmitrii S Linnik, T. Mashel, A. Muslimov, Sergey Pavlov, K. Lepik, M. Zyuzin, G. Sukhorukov, A. Timin · 2021 · Materials Science and Engineering C: Materials for Biological Applications
  48. Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo
    Yunping Hu, Baisong Lu, Zhiyong Deng, Fei Xing, Wesley Hsu · 2023 · Discover Oncology
  49. Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy
    Yu Chen, Zhen Li, Zhu Xu, Huanyin Tang, Wenxuan Guo, Xiaoxiang Sun, Wenjun Zhang, Jian Zhang, Xiaoping Wan, Ying Jiang et al. · 2018 · Cell Death and Disease
  50. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality
    Natalie M. Kofler, Katherine L. Kraschel · 2018 · Seminars in Perinatology
  51. Real‐Time Quantification of Cell Internalization Kinetics by Functionalized Bioluminescent Nanoprobes
    Di Wu, Yilong Yang, Pengcheng Xu, Duo Xu, Yang Liu, Roxanne Castillo, Ran Yan, Jie Ren, G. Wayne Zhou, Chaoyong Liu et al. · 2019 · Advanced Materials
  52. Dopamine-Grafted Hyaluronic Acid Coated Hyperbranched Poly(β-Amino Esters)/DNA Nano-Complexes for Enhanced Gene Delivery and Biosafety
    Man Guo, Yingcai Meng, Xiaoqun Qin, Wenhu Zhou · 2021 · Crystals
  53. RETRACTED ARTICLE: Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies
    Dilpreet Singh · 2024 · AAPS PharmSciTech · Retracted
  54. On‐Demand Regulation of Catalytic DNA Circuits Using Phosphorylated Charge Reversal Peptides
    Qingqing Zhang, Shanshan Yu, Shizhen He, Yuqiu He, Xiaoqing Liu, Fuan Wang · 2025 · Angewandte Chemie International Edition
  55. Non-viral Methodology for Efficient Co-transfection
    Jessica A. Kretzmann, Cameron W. Evans, Marck Nörret, Pilar Blancafort, K. Swaminathan Iyer · 2018 · Methods in molecular biology
  56. Systematic Combination of Oligonucleotides and Synthetic Polymers for Advanced Therapeutic Applications
    Moohyun Han, Jiyun Beon, Ju Young Lee, Seung Soo Oh · 2021 · Macromolecular Research
  57. Development of a Simple and Quick Method to Assess Base Editing in Human Cells
    Xiujuan Lv, Kairui Qiu, Tianxiang Tu, Xiaoxue He, Yuchen Peng, Jinbin Ye, Junhao Fu, Ruzhi Deng, Yuqin Wang, Jinyu Wu et al. · 2020 · Molecular Therapy — Nucleic Acids
  58. Blood Group Antigen Shielding Facilitated by Selective Cell Surface Engineering
    Long Jiang, Huajing Liu, Chuixiu Huang, Xiantao Shen · 2020 · ACS Applied Materials & Interfaces
  59. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology
    Joffrey Mianné, Chloé Bourguignon, Chloé Nguyen Van, Mathieu Fieldès, Amel Nasri, Saïd Assou, John De Vos · 2020 · Cells
  60. Engineered microorganism-based delivery systems for targeted cancer therapy: a narrative review.
    Xin Huang, Haoyu Guo, Lutong Wang, Zengwu Shao · 2022 · PubMed Central
  61. Protective immunity induced by a novel P1 adhesin C-terminal anchored mRNA vaccine against Mycoplasma pneumoniae infection in BALB/c mice
    Qilin Zeng, Peiyuan Sun, Weiwei Li, Yuanyuan Tang, Yuxuan Hu, Jun Mei Zhou, Yanxia Zhou, Liesong Chen, Yimou Wu · 2025 · Microbiology Spectrum
  62. Stimuli-responsive delivery strategies for controllable gene editing in tumor therapeutics
    Ji Hoon Yu, Liansheng Fan, Suchen Qu, Xin Han · 2022 · Journal of Materials Chemistry B
  63. Cell-penetrating peptide: A powerful delivery tool for DNA-free crop genome editing
    Han Wu, Kuangye Zhang, Zhipeng Zhang, Jiaxu Wang, Pengxiang Jia, Ling Cong, Jia Li, Youhou Duan, Fulai Ke, Fei Zhang et al. · 2022 · Plant Science
  64. Time-programmed activation of CD47 disruption and immunogenic cell death with Cas9 ribonucleoprotein nanocapsule for improved cancer immunotherapy
    Yumeng Xing, Jianhui Yang, Chun Wang, Ziyao Kang, Zheng Pan, Jihui Tang, Feng‐He Li, Xiao Wang, Xiao‐Ming Meng, Zhifei Cheng et al. · 2023 · Chemical Engineering Journal
  65. Emerging treatments and personalised medicine for ciliopathies associated with cystic kidney disease
    Elisa Molinari, John Andrew Sayer · 2017 · Expert Opinion on Orphan Drugs
  66. Status of Red Swamp Crayfish Aquaculture and Genetic Improvement in China
    Gen Hua Yue, Bao Lou, Zhiqiang Xu · 2025 · Reviews in Aquaculture
  67. Persistent Targeting DNA Nanocarrier Made of 3D Structural Unit Assembled from Only One Basic Multi‐Palindromic Oligonucleotide for Precise Gene Cancer Therapy
    Jingting Wu, Xiaoqi Zheng, Wenqing Lin, Linhuan Chen, Zai‐Sheng Wu · 2024 · Advanced Healthcare Materials
  68. Streamlined, single-step non-viral CRISPR-Cas9 knockout strategy enhances gene editing efficiency in primary human chondrocyte populations
    Simone Ponta, Angela Bonato, Philipp Neidenbach, Valentino F. Bruhin, Alexis E. Laurent, Lee Ann Applegate, Marcy Zenobi‐Wong, Gonçalo Barreto · 2024 · Arthritis Research & Therapy
  69. Melanin-based duplex Cas9 ribonucleoprotein nanomedicine for synergistic phototherapy and immunotherapy
    Liansheng Fan, Suchen Qu, Jing Qian, Gaoyu Shi, Qiqing Huang, Yanni Song, Yu Ji, Quli Fan, Xin Han · 2024 · Chemical Engineering Journal
  70. Regenerative rehabilitation: a novel multidisciplinary field to maximize patient outcomes
    Chunchu Deng, Fatima Aldali, Hongmei Luo, Hong Chen · 2024 · Medical Review
  71. Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma
    Asma Ghaemi, Khalil Abnous, Seyed Mohammad Taghdisi, Masoumeh Vakili-Azghandi, Mohammad Ramezani, Mona Alibolandi · 2024 · Nanomedicine Nanotechnology Biology and Medicine
  72. DNA origami-based nano-vaccines for cancer immunotherapy
    Tanvir Ahmed · 2024 · Nano Trends
  73. Ctrl-Alt-inDel: genome editing to reprogram a cell in the clinic
    Fyodor D. Urnov · 2018 · Current Opinion in Genetics & Development
  74. The inevitability of change
    Rokea A. el‐Azhary · 2018 · Clinics in Dermatology
  75. Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications
    Emily M. Mills, Victoria L. Barlow, Louis Y. P. Luk, Yu‐Hsuan Tsai · 2019 · Cell Biology and Toxicology
  76. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
    Vivian Weiwen Xue, Sze Chuen Cesar Wong, William Chi Shing Cho · 2020 · Expert Opinion on Therapeutic Targets
  77. Unlocking the potential: integrating phytoconstituents and nanotechnology in skin cancer therapy – A comprehensive review
    Abhishek Tiwari, Varsha Tiwari, Ajay Sharma, Arya Lakshmi Marrisetti, Manish Kumar, Ankit Rochani, Deepak Kumar Kaushik, Vineet Mittal, Renuka Jyothi S., Haider Ali et al. · 2024 · Journal of Complementary and Integrative Medicine
  78. A targeted approach: Gene and RNA editing for neurodegenerative disease treatment
    Chen‐Wei Huang, Wang-Zheqi Zhang, Yan Liao, Ting Hu, Jiamei Li, Changli Wang · 2025 · Life Sciences
  79. Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects
    Soumeya Ali Jaballah, Lizna Mohamed Ali, Mohammad Abdullah Jehad, Shaima Akhlaq, Tahir Aziz Rizvi, Farah Mustafa · 2025 · Journal of Molecular Biology
  80. Rethinking gene-edited crop regulation: advancing a Principle-based framework for modern biotechnology governance
    Saarani Vengadesen, Mohammad Firdaus Bin Abdul Aziz, M. G. K. Jones · 2025 · GM crops & food
  81. Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein
    Leyuan Bao, Clare Hannon, Abimael Cruz-Migoni, Denis Ptchelkine, Meiyi Sun, Ami Miller, Wilawan Bunjobpol, Camilo E. Quevedo, Mariliza Derveni, Jennifer S. Chambers et al. · 2017 · Scientific Reports
  82. In Utero Gene Therapy and Genome Editing
    Heather A. Hartman, Avery C. Rossidis, William H. Peranteau · 2018 · Current Stem Cell Reports
  83. Increasing the precision of gene editing in vitro, ex vivo, and in vivo
    Katherine P. Mueller, Jared Carlson-Stevermer, Krishanu Saha · 2018 · Current Opinion in Biomedical Engineering
  84. Optimization of precision nanofiber micelleplexes for DNA delivery
    Steven T. G. Street, Hayley C. Parkin, Lennard K. Shopperly, Josie Chrenek, Keiran Letwin, Stephanie Michelle Willerth, Ian Manners A · 2023 · Biomaterials Science
  85. Effects of Gene Delivery Approaches on Differentiation Potential and Gene Function of Mesenchymal Stem Cells
    Zhangyan Guan, Shuxun Chen, Fei Pan, Lei Fan, Dong Bai Sun · 2021 · IEEE Transactions on Biomedical Engineering
  86. Viscosity-aided electromechanical poration of cells for transfecting molecules
    Wenjing Huang, Shinya Sakuma, Naotomo Tottori, Shigeo S. Sugano, Yoko Yamanishi · 2022 · Lab on a Chip
  87. Extracellular Vesicles as Promising Vectors for CRISPR/Cas9 Delivery: Advantages, Challenges, and Clinical Implications
    Nameera Siraj, Saja Hussain Dilfy, Rafat Hamdi Abduljaleel · 2023 · Trends in Pharmaceutical Biotechnology
  88. The Emerging Era of Molecular Medicine
    Heming Tang, Ying Zhang, Yanyuan Wu, Ting Fu, Cheng Cui, Zongping Wang, Sitao Xie, Qin Wu, Weihong Tan · 2024 · ACS Nano
  89. Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation
    Sathishbabu Paranthaman, Chinnappa A. Uthaiah, Shadab Md, Huda Mohammed Alkreathy · 2025 · Advances in Colloid and Interface Science
  90. Reconfigurable Nucleic Acid Nanoparticles with Therapeutic RNAi Responses to Intracellular Disease Markers
    Yelixza I. Avila, Anh Thu Ha, Morgan R. Chandler, Nathalia Leal Santos, Tae‐Jin Kim, Hannah S. Newton, Marina A. Dobrovolskaia, Kirill A. Afonin · 2025 · Advanced Functional Materials
  91. Stem cells in organogenesis and regeneration
    Tasmia Jahin Mim, Iftakhar Ahmad, Salima Raiyan Basher, Md. Foyzur Rahman, Sandeep Reddy Ambati, Kiranmai Venkatagiri, Nimrah Seher, Dinesh Kumar, Neeraj Choudhary, Suresh Babu Kondaveeti · 2026 · Stem Cell Research & Therapy
  92. Challenges and Future Prospects of CRISPR Technology
    Zulqurnain Khan, Sultan Habibullah Khan, Aftab Ahmad · 2021 · Springer eBooks
  93. Acid‐activated nonviral peptide vector for gene delivery
    Kun Ji, Yi Xiao, Wei Zhang · 2019 · Journal of Peptide Science
  94. An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing
    Nannan Duan, Shuqing Tang, Baitao Zeng, Zhiqing Hu, Qian Hu, Lingqian Wu, Miaojin Zhou, Desheng Liang · 2021 · Life
  95. Lipid nanoparticle-enabled gene editing in the lung via inhalation
    2023 · Nature Biotechnology
  96. Advances in CRISPR/Cas9 Technology for in Vivo Translation
    Yağız Anıl Çiçek, David C. Luther, Jessica A. Kretzmann, Vincent M. Rotello · 2019 · Biological and Pharmaceutical Bulletin
  97. Genome Editing: Insights from Chemical Biology to Support Safe and Transformative Therapeutic Applications
    Renee D. Wegrzyn, Andrew H. Lee, Amy L. Jenkins, Colby D. Stoddard, Anne E. Cheever · 2017 · ACS Chemical Biology
  98. Genome Editing Approaches Using Zinc Finger Nucleases (ZFNs) for the Treatment of Motor Neuron Diseases
    Medisetti Manikishore, Sandeep Kumar Maurya, Sunny Rathee, Umesh Kumar Patil · 2024 · Current Pharmaceutical Biotechnology
  99. Non-viral intron knock-ins for targeted gene integration into human T cells and for T-cell selection
    Theodore L. Roth, Johnathan Lu, Alison K. McClellan, Courtney Kernick, Oliver Takacsi-Nagy, Ansuman T. Satpathy · 2025 · Nature Biomedical Engineering
  100. Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
    Kerui Huang, Jianhong Tian, Wenyan Zhao, Siqin Zhang, Lixuan Xiang, Meiqing Yang, Liu Ls, Y Huang, Ningyun Zhang, Lei Sun et al. · 2026 · iMetaOmics.